Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neuroblastoma × ceritinib × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 2 Noonan Syndrome 6 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Granuloma, Plasma Cell 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 ALK-positive Non-small Cell Lung Cancer 1

Interventions

Cyclophosphamide 6 Isotretinoin 5 thymoglobulin 4 fludarabine phosphate 4 fludarabine 4 Topotecan 4 Temozolomide 4 Melphalan 4 Irinotecan 4 Etoposide 4 ribociclib 3 aldesleukin 3 Thiotepa 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Bone Marrow Transplantation 3 Antilymphocyte Serum 3 temsirolimus 2 Vincristine 2 Tretinoin 2 TPI-287 2 Stem Cell Transplantation 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Interleukin-2 2 Ifosfamide 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Flow Cytometry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡